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AbstrACt
Introduction Female urinary incontinence (UI) is 
common affecting up to 45% of women. Pelvic floor 
muscle training (PFMT) is the first-line treatment 
but there is uncertainty whether intensive PFMT is 
better than basic PFMT for long-term symptomatic 
improvement. It is also unclear which factors influence 
women’s ability to perform PFMT long term and 
whether this has impacts on long-term outcomes. OPAL 
(optimising PFMT to achieve long-term benefits) trial 
examines the effectiveness and cost-effectiveness 
of basic PFMT versus biofeedback-mediated PFMT 
and this evaluation explores women’s experiences of 
treatment and the factors which influence effectiveness. 
This will provide data aiding interpretation of the trial 
findings; make recommendations for optimising the 
treatment protocol; support implementation in practice; 
and address gaps in the literature around long-term 
adherence to PFMT for women with stress or mixed UI.
Methods and analysis This evaluation comprises 
a longitudinal qualitative case study and process 
evaluation (PE). The case study aims to explore women’s 
experiences of treatment and adherence and the PE will 
explore factors influencing intervention effectiveness. 
The case study has a two-tailed design and will recruit 
40 women, 20 from each trial group; they will be 
interviewed four times over 2 years. Process data will 
be collected from women through questionnaires at 
four time-points, from health professionals through 
checklists and interviews and by sampling 100 audio 
recordings of appointments. Qualitative analysis will 
use case study methodology (qualitative study) and 
the framework technique (PE) and will interrogate for 
similarities and differences between the trial groups 
regarding barriers and facilitators to adherence. Process 
data analyses will examine fidelity, engagement and 
mediating factors using descriptive and interpretative 
statistics.
Ethics and dissemination Approval from West of 
Scotland Research Ethics Committee 4 (16/LO/0990). 
strengths and limitations of this study
 ► The strength is the design of an in-depth, pre-
planned and theoretically driven process evaluation 
(PE) and longitudinal comparative qualitative case 
study to support understanding of two complex 
interventions.
 ► This evaluation will sample from women from both 
intervention arms and professionals from all centres 
delivering the interventions.
 ► The strength of the case study is the large number 
of cases and its comparative longitudinal design that 
works in parallel with the trial to explore implemen-
tation, context and adherence to pelvic floor muscle 
training treatment regimes.
 ► The strength of the PE is the range of data for 
triangulation.
 ► The limitation of this work is that we did not col-
lect any data from sites prior to them delivering the 
interventions.
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Findings will be published in journals, disseminated at conferences and 
through the final report.
trial registration number ISRCTN57746448.
IntroduCtIon   
Urinary incontinence (UI), the involuntary loss of urine, 
is a common condition in women. The prevalence of 
UI depends on the definition, using a broad definition 
between 5% and 69% is reported but most studies report 
the range 25%–45% of women internationally.1 The 
main types of UI are stress, urgency and mixed inconti-
nence, with stress incontinence being the most prevalent 
affecting approximately 50% of women with UI; mixed 
UI affects 7.5%–25% and urgency affects approximately 
1%–7% of women with UI. The cost to the UK’s National 
Health Service (NHS) was estimated at £233 million in 
20002 and the personal costs to women estimated to be 
£178 million.3 
Pelvic floor muscle training (PFMT) is the first line 
treatment for stress and mixed UI4 and there is good 
evidence to show PFMT is effective in the short term.5 6 
However, it is not clear whether or how common inten-
sifiers of PFMT (eg, more contact with health profes-
sionals, use of adjuncts such as biofeedback) increase 
longer-term PFMT adherence and the duration of effect. 
A recent series summarising the PFMT adherence litera-
ture7–11 does suggest that self-efficacy is one factor influ-
encing women’s ability to continue to perform self-care, 
such as PFMT, after treatment but there is a need for 
more research in this area to identify the full range of 
factors and how these impact on their UI symptoms in 
the longer term.
Biofeedback (audio and/or visual feedback from a 
pressure or force-sensitive or electromyography device 
of a contraction of pelvic floor muscles) is often used as 
an adjunct to PFMT. A Cochrane review of the effective-
ness of PFMT augmented with biofeedback concluded 
that women receiving biofeedback were more likely to 
report improved symptoms or cure than women who did 
not receive biofeedback; however, the effect might be 
confounded by greater amounts of health professional 
contact in women receiving biofeedback.12 As a result, 
Hagen and colleagues are conducting a large multi-
centre randomised control trial of the effectiveness and 
cost-effectiveness of long-term adherence to basic versus 
biofeedback-mediated intensive PFMT for female stress 
or mixed UI (OPAL), with the same amount of health 
professional contact in both trial groups.13 Unique to the 
trials conducted so far in this field, the OPAL trial has 
an embedded mixed-methods process evaluation (PE) to 
explore factors impacting on short-term and long-term 
adherence to PFMT, and any other mediating factors for 
treatment delivery and effectiveness. This PE will draw 
on analysis of multiple datasets generated throughout 
the trial including the interviews with the therapists, 
audio recorded consultations, treatment checklists and 
trial participant questionnaires, as well as on the findings 
from the longitudinal qualitative interviews exploring 
women’s experiences of the OPAL intervention.
the oPAL trial
The OPAL trial is a large multicentre, pragmatic 
randomised controlled trial of two active treatment inter-
ventions, basic PFMT and biofeedback-mediated PFMT 
for the treatment of stress or mixed UI. The trial has been 
fully described in the companion trial protocol paper and 
further information is available on the trial website ( www. 
opaltrial. co. uk). In brief, ‘Intensive’ PFMT consists of 
basic PFMT with adjunctive biofeedback at every clinic 
appointment and at home. Both ‘basic’ and ‘intensive’ 
treatment groups are offered six clinic appointments 
over the 16-week intervention period. Women in both 
groups receive pelvic floor muscle assessment,14 vaginal 
palpation, verbal feedback and individualised exercise 
prescription based on this assessment, advice for bowel 
and bladder symptoms and tailored lifestyle advice. Treat-
ment is delivered by women’s health physiotherapists or 
continence nurses who have received training designed 
and delivered by the trial team.13 The premise is that 
biofeedback will intensify PFMT by offering women more 
visible information about exercise outcomes, support 
motivation and enhance behavioural skill (eg, improved 
contraction technique and confidence). The anticipated 
outcome of adjunctive biofeedback is improved quality 
and quantity of exercise, with the expectation that this 
will increase treatment benefit and reduce symptoms. 
However, the biofeedback intervention can only work to 
intensify PFMT if women use the device.
the oPAL longitudinal qualitative case study and PE
The OPAL evaluation has a comprehensive and well-re-
sourced longitudinal qualitative comparative case study 
and mixed-method PE running parallel to the trial to 
provide important insights into the trial’s processes and 
outcomes: to explain how the interventions worked (what 
factors led to the observed effect); assist in interpretation 
of the trial findings; and facilitate transferability into clin-
ical practice (if effective) and further research (in partic-
ular if not effective). This design is rather unusual but 
allows the researchers to preserve multiple perspectives 
and contribute to the robustness of the complex analysis 
of factors mediating the trial delivery and findings. These 
studies will be cross-referenced to support more compre-
hensive explanations of how the interventions work and 
assist in interpreting the trial findings. We describe each 
study in more detail below:
The qualitative case study is longitudinal in nature to 
mirror the trial data collection, to capture the dynamic 
nature of treatment delivery and participants’ experi-
ences, to generate more in-depth data about what works 
well (or not) when intensifying treatment regimens, 
and most importantly, in this trial to better understand 
the factors important to long-term adherence to PFMT. 
Within the trials literature, this longitudinal method-
ological design is rare, but it is needed to capture the 
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dynamic nature of implementation and adherence to 
long-term PFMT treatment regimens; furthermore, the 
commissioning call for this work explicitly requested a 
qualitative study to explore women’s experience and 
barriers to adherence. This qualitative case study will 
also make an important contribution to understanding 
the behavioural aspects of therapy which are rarely 
documented.
The PE aims to provide transparency by exploring 
the implementation of the interventions in context.15 
Variation in implementation of the OPAL interventions 
is likely to be due to: the different intervention compo-
nents; the diverse clinical settings (university hospital, 
district general hospital, community settings) and 
health professionals delivering (women’s health physio-
therapists and incontinence specialist nurses); and, the 
contextual and personal differences between women 
receiving the interventions and adhering to PFMT 
long-term. These different factors are likely to influ-
ence how well the interventions are integrated within 
existing practice and women’s lives and may impact on 
the trial findings. As a result, we believe it is important 
to explore delivery (including fidelity and dose—if 
the intervention components are being delivered as 
intended and in what quantity across the different trial 
centres), response (participant’s experiences of the 
intervention) and maintenance (how and why these 
processes are sustained over time or not by women 
and therapists during the intervention delivery and by 
women after the intervention delivery is complete).15 
For delivery, we are particularly interested in fidelity of 
function16 as clinicians were given a protocol to follow 
with the expectation that they would individualise this 
(the exact exercise prescription, lifestyle advice and so 
on) to the care each woman required; however, there 
were also specific behaviour change techniques that 
were to be used for all women (and not individualised) 
and so we will also be investigating fidelity of form for 
this element of the interventions. Women’s experi-
ences of receiving treatment in the clinic and how they 
engage with PFMT at home is important to how they 
respond to the interventions. As OPAL is interested 
in long-term adherence to PFMT, it is important to 
explore how women maintain their adherence (or not) 
and the factors which facilitated or impeded this. It is 
hypothesised that self-efficacy will be a mediating factor 
to intervention effectiveness. The longitudinal qualita-
tive case study will support the PE by providing data on 
‘response’ and ‘maintenance’ to explain the women’s 
experiences of receiving treatment, how and why they 
engaged with PFMT and/or biofeedback PFMT in the 
clinic and at home during treatment and how and why 
they maintained engagement (or not) over time.
Aim and objectives
The overall aim of this mixed method evaluation is to 
understand why the interventions were effective or inef-
fective, understand implementation and the issues in 
short-term and long-term adherence to PFMT and to 
inform wider implementation (or further research if 
ineffective) as well as the PFMT intervention literature. 
Although interlinked, we describe each parallel evalua-
tion (see figure 1) separately to facilitate clarity as each 
evaluation has a specific objective.
Longitudinal comparative qualitative case study objectives
The objectives were to investigate women’s experiences 
of the interventions, both basic and intensive PFMT, to 
identify the barriers and facilitators which impact on 
adherence in the short-term and long-term, to explain 
the process through which they influence adherence 
and to identify whether these differ between randomised 
groups.
PE objective
The objectives were to identify and investigate the possible 
mediating factors that impact the effectiveness of the 
intervention (including intervention fidelity), how these 
mediating factors influence effectiveness and whether the 
factors differ between randomised groups.
Management and governance
The trial was registered on the ISRCTN registry (ISRCTN 
57746448).
The longitudinal comparative qualitative case study 
and PE management group has a mix of relevant clin-
ical, qualitative, quantitative and theoretical skills and 
experience17 and meets regularly to discuss the research 
management and emerging findings. In order to ensure 
allocation concealment is maintained, it has been 
agreed that this team will not discuss or present find-
ings from this study with any staff from the main trial 
project management group. As a result, these meetings 
are closed.
MEthods And AnALysIs
Methods for longitudinal comparative qualitative case study
A longitudinal, qualitative, two-tailed case study design18 
utilising semistructured interviews with purposively 
sampled women from both groups to explore the expe-
rience of, and adherence to, the trial interventions. The 
tails will be the experimental and comparator groups of 
the trial. Using a two-tailed case study design comple-
ments the trial design in its comparative focus. The 
analysis, like the trial analysis, is set up to explore differ-
ences between the ‘tails’ or groups. In the case study 
design, the differences can be exposed and support 
understanding of effectiveness (or non-effectiveness).
sampling and recruitment strategy
Thirty to 40 randomised women (15 to 20 in each tail) 
will be purposively sampled for variance in centre type 
(district general hospital, university hospital, community 
delivered service), women’s type of UI (stress or mixed) 
and therapist type (physiotherapist/nurse), as case 
studies. Purposively selected women, who have consented 
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to the trial, will be given an additional information leaflet 
and asked if they are interested in taking part in an inter-
view study. Interested women will be contacted by tele-
phone approximately a week later to ask if they would like 
to participate. If a woman declines to consent to the inter-
view study, another woman with similar characteristics will 
be selected and approached. Formal written consent will 
be collected at the time of the first face-to-face interview. 
We anticipate some attrition of women by the 12-month 
and 24-month interviews, however, we have oversampled 
to ensure sufficient heterogeneity to identify barriers 
and facilitators to respond to the interventions, and to 
generate hypotheses about the factors associated with 
differing outcomes, including long-term adherence to 
PFMT.
Qualitative data collection
Data will be collected by a series of semistructured inter-
views at baseline, 6, 12 and 24 months (12 and 24 months 
by telephone). Each interview will have a specific focus:
 ► Baseline (pretreatment) interview (face-to-face) will 
explore the woman’s experience of UI, the social 
contexts within which she experiences UI and her 
expectations of treatment.
 ► Six-month interview (face-to-face) will explore 
the woman’s experience of the trial intervention, 
her adherence to therapy appointments and the 
prescribed programme, and factors that affected that 
adherence and her perceptions of treatment outcome.
 ► 12-month interview (telephone) will explore the 
woman’s experience of UI postintervention, of the 
Figure 1 Trial flow diagram. PFMT, pelvic floor muscle training. 
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intervention, of factors that influence ongoing adher-
ence to PFMT and of treatment outcome.
 ► 24-month interview (telephone) will explore the 
same issues as at 12 months but with a focus on the 
longer term.
Interview data will be collected using a password 
protected audio digital recorder.
Qualitative case study data analysis
Interview audio recordings will be transcribed verbatim 
and entered into QSR NVivo software to support analysis. 
The analysis will be iterative with data generation and will 
take place on four interacting levels to facilitate within 
and cross-case comparisons to ensure comprehensive 
examination which exposes the similarities and differ-
ences between the experimental and comparator groups 
and identifies barriers and facilitators to adherence:
 ► At the level of the individual interview. An initial a priori 
coding scheme will be applied that focuses on core 
areas of interest: specifically, women’s experiences 
of UI; experience of PFMT +/−biofeedback; factors 
that influence adherence to supervised treatment 
and home exercise; and perceptions of treatment 
outcome. Research team discussions and constant iter-
ative coding will further develop the coding scheme. 
The combination of the a priori scheme and inductive 
codes will aim, at this stage, to identify barriers and 
facilitators that influence adherence.
 ► At the level of the case (woman). Case summaries will be 
written with a focus on creating an understanding 
of women’s experience in our areas of interest: the 
problem, the treatment, adherence to supervised 
treatment and home exercise; perceptions of treat-
ment outcome and how these factors interact. Analysis 
at this stage will focus on identifying issues relating to 
changes over time and in developing theoretical prop-
ositions to guide subsequent analysis (Yin 2003).
 ► At the level of the trial group. All the cases for one trial 
group will be collected together and consistencies/
inconsistencies searched for. The aim of analysis at 
this stage is to identify the core barrier and facilitators 
within the trial group, the detailed explanations for 
them and interactions between them.
 ► At the tail level. The experimental and comparator tails 
will be compared with one another using the theoret-
ical propositions. The aim of the analysis at this point 
is to identify similarities and differences in barriers 
and facilitators between the trial groups.
Methods for PE
This mixed methods PE will focus on assessing the fidelity 
of function (with additional checking of fidelity of form 
for the behavioural change techniques)16 and explore 
delivery and implementation with therapists delivering 
the interventions in all centres. Fidelity will be assessed 
using theory-based and protocol-linked checklists 
completed by therapists at each appointment a woman 
attends and audio recordings of a purposive sample of 
100 therapy appointments which will be assessed against a 
theory-driven framework derived from the trial protocol. 
Qualitative telephone interviews will be conducted with 
health professionals delivering the interventions at the 
end of their involvement in the trial. This is a concurrent 
study design with all methods being used simultaneously.
PE sampling and recruitment strategy and data collection
1. A protocol checklist will be completed by all therapists 
after each appointment. The checklist will allow assess-
ment of protocol deviations (as defined in the main tri-
al and for statistical analysis purposes). It will also allow 
explanation of the clinically informed and permitted 
variance in delivery through tailoring of the interven-
tion based on individual women’s needs; alongside an 
explanation of the reasons, the variance occurred.
2. Audio recordings will be conducted with a purposive 
sample of 100 appointments. These will be sampled for 
heterogeneity across: the comparator and experimen-
tal groups; the different therapy appointments (in both 
groups, six therapy appointments across 16 weeks); 
centre (aiming for inclusion of appointments at all 
centres); woman’s type and severity of UI; and ther-
apist type (physiotherapist or incontinence nurse). 
Each centre will be provided with a password-protected 
audio digital recorder to record the selected appoint-
ments. We will aim to oversample audio recordings for 
the first and last appointments due to our a priori hy-
pothesis that treatment delivery may be more intensive 
and concentrated in the first and last appointments. 
The first appointment is a longer consultation and 
involves important education and training for being 
taught how to properly perform PFMT, where relevant 
including the teaching of biofeedback, and for under-
standing any changes to lifestyle that may be recom-
mended. The last appointment is important because 
therapy is coming to an end and women are being giv-
en important information to allow them to self-care, 
such as instructions regarding the maintenance dose 
of PFMT. If participants have signed on their consent 
form that they are willing to have an appointment au-
dio recorded, the researcher will purposively select 
participants and telephone them to ask if they would 
be willing to have a specific appointment recorded, an-
swer any questions they may have and to take verbal 
consent. Therapists will then be informed which par-
ticipants and appointments to record. The audio re-
cording devices will be returned to the researcher at 
regular intervals to download the data and to ensure 
the audio consultations are transcribed verbatim.
3. Semistructured telephone interviews will be undertak-
en with therapists who have been involved in deliver-
ing the interventions at the end of their participation. 
We aim to interview at least one therapist from each 
site. A topic guide developed from the literature and 
from issues which have arisen during delivery of the in-
tervention and from patient interviews will be utilised. 
The interviews will explore the therapist’s experiences 
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of delivering the PFMT and BF PFMT interventions, 
including their perspectives on adherence to deliver-
ing the protocols and women’s adherence to the inter-
vention.
4. The trial follow-up questionnaires will include ques-
tions on women’s adherence and self-efficacy to PFMT 
during and after the supervised intervention which 
will contribute to the PE. These data will be analysed 
like secondary outcome measures (please see Hagen et 
al for more details).13 In addition, the interview study 
(described earlier) will provide data from the women 
about adherence to treatment to feed into the PE.
PE analysis
Each data source will be analysed individually in the first 
instance to reach separate conclusions:
1. Data from the checklists completed by the therapists 
will be summarised descriptively to report the extent 
to which there were consistent with the protocol. Free-
text comments from the therapists relating to any bar-
riers and facilitators to delivering the protocol and any 
variations due to individual tailoring they experienced 
during appointments will be coded using a coding 
framework developed using content analysis with a 
10% representative sample of appointments.
2. Data from interviews with therapists will be analysed 
using the Framework Approach (Ritchie et al).19 Fol-
lowing familiarisation with the data, a thematic frame-
work will be developed and applied across the data set. 
Data will then be tabulated and conceptual maps used 
to make links between themes. Where possible in vivo 
codes and concepts will be utilised.
3. A quantitative coding scheme will be developed for 
analysis of the appointment audio recordings. This 
coding scheme will be developed using the interven-
tion protocols and the theory underlying the proto-
cols, and data generated from a purposive sample of 
recordings (treatment arm, visit number and site). 
The coding scheme will contain explicit guidance as to 
what codes have to be applied in what circumstances. 
The audio recordings will then be coded and entered 
into SPSS. Coded data will then be subject to descrip-
tive and interpretive analyses.
4. Data from the main study self-report questionnaires 
will be analysed in line with the Statistical Analysis 
Plan. Specifically, and as indicated in the main stan-
dard operating procedure, we will undertake a medi-
ational analysis as part of the quantitative PE, and this 
will focus on the self-efficacy data as our hypothesised 
mediating variable. The details of the mediational 
analyses are described in the PE analysis plan.
synthesising the data from the longitudinal comparative case 
study and the PE
Synthesis will be undertaken once both analyses are 
complete, where the case study analysis will be cross-refer-
enced and synthesised with the PE findings. Data synthesis 
will be undertaken whereby the findings from individual 
data sources will be presented in matrices that bring 
together key issues from the different analyses to draw 
hypotheses about why the intervention components were 
implemented more successfully than others and explore 
if there is a synergistic effect and if these are related to 
patient’s experiences of BF PFMT and PFMT treatment. 
We will also elucidate the causal mechanisms which lead 
to change (or not) in each arm and suggest which compo-
nents of the interventions were more successful and why. 
The combined data will also allow us to present a nuanced 
analysis of context. This will provide important informa-
tion about the implementation of the interventions and 
if and how the interventions can be transferred to other 
settings.
Integration of the case study, PE and trial findings
Both studies will be analysed separately before the 
outcome of the trial is known and the main trial will be 
analysed without knowledge of the longitudinal case 
study and PE findings.20 The main trial research team and 
the research team have agreed that no case study/PE data 
will be shared before the trial code is broken. Following 
the identification of the main trial findings, subsequent 
analysis of the case study and PE data will be undertaken. 
There will be transparency in reporting which findings 
were identified prior to, and after, the trial findings were 
known.
Public patient involvement
OPAL has a woman who has experience of UI as a 
grant holder and has patient representation on the Trial 
Steering Committee. Through these inputs, the research 
question, outcome measures and study design have 
all had women’s perspectives included. Patient-facing 
recruitment materials were all reviewed by women with 
UI. Women were not involved in other aspects or study 
recruitment or conduct. Participants will all receive a lay 
summary of the results of the study. The burden of the 
intervention was assessed by our grant holder with UI. 
Our grant holder is named as an author on our main trial 
protocol paper.
EthICs And dIssEMInAtIon
The study will be conducted in accordance with the 
ICH GCP Note for Guidance on Good Clinical Practice. 
Favourable ethics opinion covering recruitment across 
all UK NHS centres was obtained and approved from 
the Regional NHS Ethics Committee and local R&D 
departments.
Final trial results will be disseminated to the funding 
body, the NIHR Health Technology Assessment 
Programme. The trial results will be then submitted to 
peer-reviewed journals and presented at international 
conferences. Participants will be provided with a summary 
of the results.
study timelines
Funding for this study was approved on the 14 August 
2012.
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The Trial and qualitative evaluation and PE all started on 
1 September 2013 and finished on 30 November 2018.
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